Lu Y - Search Results

1

Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer.

Zhu X, Lu Y, Lu H, Yang W, Tu X, Cai X, Zhou X. Zhu X, et al. Among authors: lu y, lu h. Hum Pathol. 2011 Oct;42(10):1499-504. doi: 10.1016/j.humpath.2010.04.023. Epub 2011 Jun 14. Hum Pathol. 2011. PMID: 21676436

2

Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma.

Huang W, Li X, Yao X, Lu Y, Li B, Sheng W, Lu H, Jin A, Zhou X. Huang W, et al. Among authors: lu y, lu h. Exp Mol Pathol. 2009 Apr;86(2):121-6. doi: 10.1016/j.yexmp.2008.11.012. Epub 2008 Dec 14. Exp Mol Pathol. 2009. PMID: 19135051

3

[Assessment of HER2 gene amplification in breast cancer: a comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization].

Xu Y, Yang W, Yang F, Lu Y, Cai X, Zhou X. Xu Y, et al. Among authors: lu y. Zhonghua Bing Li Xue Za Zhi. 2014 Apr;43(4):226-30. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 24915811 Chinese.

4

Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.

Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X, Zhu X. Zhu X, et al. Among authors: lu y, lu h. J Clin Pathol. 2010 Sep;63(9):786-9. doi: 10.1136/jcp.2010.076901. Epub 2010 Jul 19. J Clin Pathol. 2010. PMID: 20644217

5

Clinicopathological characteristics and her-2/neu status in chinese patients with uterine papillary serous carcinoma.

Ren Y, Wang H, Zhou X, Yang W, Huang X, Lu Y, Shi D. Ren Y, et al. Among authors: lu y. ISRN Obstet Gynecol. 2011;2011:575327. doi: 10.5402/2011/575327. Epub 2010 Oct 20. ISRN Obstet Gynecol. 2011. PMID: 21647234 Free PMC article.

6

Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma.

Zhu X, Luo Y, Bai Q, Lu Y, Lu Y, Wu L, Zhou X. Zhu X, et al. Among authors: lu y. Exp Mol Pathol. 2016 Feb;100(1):236-41. doi: 10.1016/j.yexmp.2016.01.004. Epub 2016 Jan 13. Exp Mol Pathol. 2016. PMID: 26795218

7

Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement.

Tang S, Yang F, Du X, Lu Y, Zhang L, Zhou X. Tang S, et al. Among authors: lu y. Int J Gynecol Pathol. 2016 Jul;35(4):337-47. doi: 10.1097/PGP.0000000000000260. Int J Gynecol Pathol. 2016. PMID: 27271776

8

Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review.

Zhu X, Bai Q, Lu Y, Qi P, Ding J, Wang J, Zhou X. Zhu X, et al. Among authors: lu y. Target Oncol. 2017 Feb;12(1):81-88. doi: 10.1007/s11523-016-0455-4. Target Oncol. 2017. PMID: 27538584 Review.

9

Correlation between clinicopathological features and KRAS, NRAS, and BRAF mutation status in Chinese colorectal cancer patients.

Zhu X, Meng X, Xiang W, Dai W, Bai Q, Sheng W, Lu Y, Qi P, Wu L, Cai G, Zhou X. Zhu X, et al. Among authors: lu y. Int J Clin Exp Pathol. 2018 May 1;11(5):2839-2845. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938404 Free PMC article.

10

Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.

Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, Cai X, Yu BH, Du YQ. Yan SY, et al. Among authors: lu ym. World J Gastroenterol. 2011 Mar 21;17(11):1501-6. doi: 10.3748/wjg.v17.i11.1501. World J Gastroenterol. 2011. PMID: 21472111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,208 results

Search Page

Filters